The histone deacetylase inhibitor butyrate improves metabolism and reduces muscle atrophy during aging

ME Walsh, A Bhattacharya, K Sataranatarajan… - Aging cell, 2015 - Wiley Online Library
Sarcopenia, the loss of skeletal muscle mass and function during aging, is a major
contributor to disability and frailty in the elderly. Previous studies found a protective effect of …

The histone deacetylase inhibitor butyrate improves metabolism and reduces muscle atrophy during aging.

ME Walsh, A Bhattacharya, K Sataranatarajan… - Aging Cell, 2015 - europepmc.org
Sarcopenia, the loss of skeletal muscle mass and function during aging, is a major
contributor to disability and frailty in the elderly. Previous studies found a protective effect of …

[引用][C] The histone deacetylase inhibitor butyrate improves metabolism and reduces muscle atrophy during aging

ME Walsh, A Bhattacharya, K Sataranatarajan… - Aging Cell, 2015 - cir.nii.ac.jp
The histone deacetylase inhibitor butyrate improves metabolism and reduces muscle atrophy
during aging | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …

[PDF][PDF] The histone deacetylase inhibitor butyrate improves metabolism and reduces muscle atrophy during aging

ME Walsh, A Bhattacharya, K Sataranatarajan… - 2015 - cyberleninka.org
Sarcopenia, the loss of skeletal muscle mass and function during aging, is a major
contributor to disability and frailty in the elderly. Previous studies found a protective effect of …

[PDF][PDF] The histone deacetylase inhibitor butyrate improves metabolism and reduces muscle atrophy during aging

ME Walsh, A Bhattacharya, K Sataranatarajan… - 2015 - Citeseer
Sarcopenia, the loss of skeletal muscle mass and function during aging, is a major
contributor to disability and frailty in the elderly. Previous studies found a protective effect of …

[HTML][HTML] The histone deacetylase inhibitor butyrate improves metabolism and reduces muscle atrophy during aging

ME Walsh, A Bhattacharya, K Sataranatarajan… - Aging Cell, 2015 - ncbi.nlm.nih.gov
Sarcopenia, the loss of skeletal muscle mass and function during aging, is a major
contributor to disability and frailty in the elderly. Previous studies found a protective effect of …

The histone deacetylase inhibitor butyrate improves metabolism and reduces muscle atrophy during aging

ME Walsh, A Bhattacharya, K Sataranatarajan… - Aging …, 2015 - pubmed.ncbi.nlm.nih.gov
Sarcopenia, the loss of skeletal muscle mass and function during aging, is a major
contributor to disability and frailty in the elderly. Previous studies found a protective effect of …

The histone deacetylase inhibitor butyrate improves metabolism and reduces muscle atrophy during aging

ME Walsh, A Bhattacharya, K Sataranatarajan… - Aging …, 2015 - search.proquest.com
Sarcopenia, the loss of skeletal muscle mass and function during aging, is a major
contributor to disability and frailty in the elderly. Previous studies found a protective effect of …

The histone deacetylase inhibitor butyrate improves metabolism and reduces muscle atrophy during aging.

ME Walsh, A Bhattacharya, K Sataranatarajan… - Aging Cell, 2015 - europepmc.org
Sarcopenia, the loss of skeletal muscle mass and function during aging, is a major
contributor to disability and frailty in the elderly. Previous studies found a protective effect of …